Paper17523697
Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G. Paediatr Drugs, 2007. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Calcineurin inhibitors in pediatric renal transplant recipients. Papers, record 17523697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17523697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcineurin Inhibitors | Major topic |
| Cyclosporine | Major topic |
| Graft Rejection | Major topic |
| Immunosuppressive Agents | Major topic |
| Kidney Transplantation | Major topic |
| Tacrolimus | Major topic |
| Child | |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12176634 | One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. | Transplant Proc | 2002 | https://conductscience.org/library/papers/12176634 | PubMed |
| 2 | 16235347 | Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. | Cochrane Database Syst Rev | 2005 | https://conductscience.org/library/papers/16235347 | PubMed |
| 3 | 7506654 | Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. | Drugs | 1993 | https://conductscience.org/library/papers/7506654 | PubMed |
| 4 | 16003231 | A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. | Transplantation | 2005 | https://conductscience.org/library/papers/16003231 | PubMed |
| 5 | 7988626 | Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7988626 | PubMed |
| 6 | 16157605 | Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. | BMJ | 2005 | https://conductscience.org/library/papers/16157605 | PubMed |
| 7 | 14961991 | Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. | Am J Transplant | 2004 | https://conductscience.org/library/papers/14961991 | PubMed |
| 8 | 12234317 | Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. | Kidney Int | 2002 | https://conductscience.org/library/papers/12234317 | PubMed |
| 9 | 9269646 | Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. | Nephrol Dial Transplant | 1997 | https://conductscience.org/library/papers/9269646 | PubMed |
| 10 | 9195117 | Cyclosporin pharmacokinetics in paediatric transplant recipients. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9195117 | PubMed |
| 11 | 11956848 | Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. | Pediatr Nephrol | 2002 | https://conductscience.org/library/papers/11956848 | PubMed |
| 12 | 16048603 | Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. | Pediatr Transplant | 2005 | https://conductscience.org/library/papers/16048603 | PubMed |
| 13 | 1373536 | Morphological and functional changes of islets of Langerhans in FK506-treated rats. | Transplantation | 1992 | https://conductscience.org/library/papers/1373536 | PubMed |
| 14 | 15265168 | Hypertension and end-organ damage in pediatric renal transplantation. | Pediatr Transplant | 2004 | https://conductscience.org/library/papers/15265168 | PubMed |
| 15 | 15834618 | Long-term outcomes of children with end-stage renal disease. | Pediatr Nephrol | 2005 | https://conductscience.org/library/papers/15834618 | PubMed |
| 16 | 14710781 | Current immunosuppressive agents: efficacy, side effects, and utilization. | Pediatr Clin North Am | 2003 | https://conductscience.org/library/papers/14710781 | PubMed |
| 17 | 7691501 | Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. | Drugs | 1993 | https://conductscience.org/library/papers/7691501 | PubMed |
| 18 | 15041300 | Cyclosporine as a milestone in immunosuppression. | Transplant Proc | 2004 | https://conductscience.org/library/papers/15041300 | PubMed |
| 19 | 12581323 | Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children. | Pediatr Transplant | 2003 | https://conductscience.org/library/papers/12581323 | PubMed |
| 20 | 15367278 | What is the calcineurin inhibitor of choice for pediatric renal transplantation? | Pediatr Transplant | 2004 | https://conductscience.org/library/papers/15367278 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599206 | Population Pharmacokinetics Model of Cyclosporin A in Children and Young Adult Renal Transplant Patients: Focus on Haemoglobin Contribution to Exposure Variability. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599206 | PubMed |
| 40229569 | Donor-derived cell-free DNA testing in pediatric kidney transplant recipients: indications and clinical utility. | Pediatr Nephrol | 2025 | https://conductscience.org/library/papers/40229569 | PubMed |
| 37665282 | Ionized Magnesium Correlates With Total Blood Magnesium in Pediatric Patients Following Kidney Transplant. | Ann Lab Med | 2024 | https://conductscience.org/library/papers/37665282 | PubMed |
| 36676680 | Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/36676680 | PubMed |
| 35631618 | Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631618 | PubMed |
| 35018303 | An Unusual Presentation of Posterior Reversible Encephalopathy Syndrome Following Liver Transplantation. | Transplant Direct | 2022 | https://conductscience.org/library/papers/35018303 | PubMed |
| 31897714 | Management of dyslipidemia in pediatric renal transplant recipients. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/31897714 | PubMed |
| 31840013 | Predicting Health Care Utilization and Charges Using a Risk Score for Poor Adherence in Pediatric Kidney Transplant Recipients. | Clin Pract Pediatr Psychol | 2018 | https://conductscience.org/library/papers/31840013 | PubMed |
| 31507644 | Tuberculum sellae meningioma with possible tacrolimus neurotoxicity manifesting as manic-like psychosis after kidney transplantation. | Ann Gen Psychiatry | 2019 | https://conductscience.org/library/papers/31507644 | PubMed |
| 28828166 | Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes. | Int J Organ Transplant Med | 2017 | https://conductscience.org/library/papers/28828166 | PubMed |
| 28507917 | Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant. | World J Transplant | 2017 | https://conductscience.org/library/papers/28507917 | PubMed |
| 27721357 | Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients. | Pharmaceutics | 2010 | https://conductscience.org/library/papers/27721357 | PubMed |
| 26921212 | The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. | Pediatr Nephrol | 2017 | https://conductscience.org/library/papers/26921212 | PubMed |
| 24861769 | Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin. | Int J Clin Pharm | 2014 | https://conductscience.org/library/papers/24861769 | PubMed |
| 23690247 | Refractory intracranial hypertension in posterior reversible encephalopathy syndrome. | Neurocrit Care | 2013 | https://conductscience.org/library/papers/23690247 | PubMed |
| 20872191 | Myoblast transplantation: a possible surgical treatment for a severe pediatric disease. | Surg Today | 2010 | https://conductscience.org/library/papers/20872191 | PubMed |
| 18228043 | Nephrotoxicity as a cause of acute kidney injury in children. | Pediatr Nephrol | 2008 | https://conductscience.org/library/papers/18228043 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17523697
GET https://conductscience.org/api/papers/v1/17523697/references?page=2